Al-Razi Medical Company (TADAWUL: 9572)

Al-Razi Medical Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	0.09	0.69	2.01	2.16
Depreciation & Amortization	3.81	3.69	2.68	2
Loss (Gain) From Sale of Assets	-0.02	-0.01	-	-
Provision & Write-off of Bad Debts	0	0.01	0.01	-
Other Operating Activities	0.57	0.73	0.52	0.6
Change in Accounts Receivable	-0.32	-0.03	-0.57	-0.14
Change in Inventory	0.86	0.43	-5.31	-1.61
Change in Accounts Payable	0.72	0.59	1.81	-1.08
Change in Other Net Operating Assets	0.35	-0.32	0.9	-3.64
Operating Cash Flow	6.06	5.78	2.05	-1.71
Operating Cash Flow Growth	95.29%	181.34%	-	-
Capital Expenditures	-6.15	-4.78	-2.69	-1.11
Sale of Property, Plant & Equipment	0.03	0.03	-	-
Sale (Purchase) of Intangibles	-0.28	-0.29	-0.23	-0.04
Investing Cash Flow	-6.4	-5.04	-2.92	-1.15
Long-Term Debt Issued	-	3	-	-
Long-Term Debt Repaid	-	-2.28	-2.87	-2.02
Net Debt Issued (Repaid)	-0.6	0.72	-2.87	-2.02
Issuance of Common Stock	-	-	-	12.4
Common Dividends Paid	-0.6	-2.41	-1.89	-
Other Financing Activities	-0.36	0.4	-0.69	-0.05
Financing Cash Flow	-1.56	-1.29	-5.45	10.33
Net Cash Flow	-1.9	-0.55	-6.32	7.47
Free Cash Flow	-0.09	1	-0.64	-2.82
Free Cash Flow Margin	-0.14%	1.63%	-1.22%	-6.25%
Free Cash Flow Per Share	-0.06	0.66	-0.42	-1.86
Levered Free Cash Flow	-1	-0.27	-1.88	-
Unlevered Free Cash Flow	-0.67	0.03	-1.7	-
Change in Net Working Capital	-1.56	-0.54	3.06	-

Source: S&P Capital IQ. Standard template. Financial Sources.